UK Companies House feature
HD CLINICAL LIMITED
Cash
£429K
-3.6% vs 2023
Net assets
-£220K
-138.3% vs 2023
Employees
59
+11.3% vs 2023
Profit before tax
-£1M
-74.1% vs 2023
Profile
- Company number
- 05436117
- Status
- Active
- Incorporation
- 2005-04-26
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62012
Net assets
7-year trend · vs UK AI & Enterprise SaaS median
Accounts
7-year trend · latest 2024-12-31
| Metric | Trend | 2020-11-01 | 2021-10-31 | 2021-11-01 | 2022-10-31 | 2022-11-01 | 2023-10-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | £2,872,048 | — | £3,209,256 | — | £3,318,267 | £3,722,122 | |
| Operating profit | — | £52,217 | — | £31,227 | — | -£619,253 | -£1,065,268 | |
| Profit before tax | — | £54,837 | — | £43,466 | — | -£615,913 | -£1,072,003 | |
| Net profit | — | £221,865 | — | £227,876 | — | -£398,480 | -£813,963 | |
| Cash | — | £1,174,436 | — | £1,059,104 | — | £445,272 | £429,220 | |
| Total assets less current liabilities | — | £775,500 | — | £1,010,701 | — | £620,262 | -£172,476 | |
| Net assets | — | £735,300 | — | £968,101 | — | £575,262 | -£220,276 | |
| Equity | £506,897 | £735,300 | £735,300 | £968,101 | £968,101 | £575,262 | -£220,276 | |
| Average employees | — | 39 | — | 42 | — | 53 | 59 | |
| Wages | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Price Bailey LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company's forecasts and projections along with post balance sheet date cash balances, trading performance and sales pipeline show that the company will be able to operate within the level of its cash resources. The directors have considered that they will have sufficient positive cash flow from recurring maintenance revenues and new product sales to enable the business to continue trading. Therefore, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for at least 12 months for the date of approval of the financial statements, thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Significant events
- “The accounting period was changed to align with that of the ultimate parent Company.”
- “All share options were exercised prior to the sale and so none remain at the year-end.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHITE, Susanna Elizabeth | Secretary | 2014-09-08 | — | — |
| ARROWSMITH, Paul Jonathan | Director | 2021-07-01 | Jan 1965 | British |
| COULL, Mark | Director | 2013-01-22 | Jun 1971 | British |
| HEILIG, Ralf | Director | 2024-10-03 | May 1966 | German |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARKER, Catherine Jennifer | Secretary | 2005-04-26 | 2009-08-31 |
| THOMAS, Howard | Secretary | 2005-04-26 | 2005-04-26 |
| TWEMLOW, Clare Gillian | Secretary | 2010-09-15 | 2014-07-15 |
| WILSON WATERWORTH, Tobias Adam | Secretary | 2009-08-31 | 2010-09-15 |
| BALCON, Raphael, Dr | Director | 2005-06-22 | 2008-01-15 |
| BARKER, David | Director | 2005-06-22 | 2009-06-01 |
| BOOTH, Robert Alec | Director | 2011-06-15 | 2011-10-03 |
| DAVIES, Timothy Keith | Director | 2005-06-22 | 2011-12-31 |
| HURRELL, Thomas Andrew | Director | 2018-07-23 | 2019-08-05 |
| LAYTON, Charlotte | Director | 2019-10-02 | 2024-10-03 |
| LAYTON, Clive Allan, Dr | Director | 2005-04-26 | 2024-10-03 |
| ROTHMAN, Martin Terry, Professor | Director | 2005-04-27 | 2024-10-03 |
| TESTER, William | Director | 2005-04-26 | 2005-04-26 |
| WHITE, Paul Morrow | Director | 2010-03-24 | 2011-11-30 |
| WILSON WATERWORTH, Tobias Adam | Director | 2006-01-24 | 2010-10-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nexus Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-10-03 | Active |
| Dr Clive Allan Layton | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2024-10-03 |
Filing timeline
Last 20 of 161 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-06 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-09-25 | AA | accounts | accounts with accounts type full |
| 2024-10-28 | AA01 | accounts | change account reference date company current extended |
| 2024-10-17 | SH01 | capital | capital allotment shares |
| 2024-10-04 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-10-04 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-10-04 | AP01 | officers | appoint person director company with name date |
| 2024-10-04 | TM01 | officers | termination director company with name termination date |
| 2024-10-04 | TM01 | officers | termination director company with name termination date |
| 2024-10-04 | TM01 | officers | termination director company with name termination date |
| 2024-10-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-07-25 | RESOLUTIONS | resolution | resolution |
| 2024-07-25 | MA | incorporation | memorandum articles |
| 2024-03-20 | AA | accounts | accounts with accounts type full |
| 2024-02-01 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2024-01-15 | SH01 | capital | capital allotment shares |
| 2024-01-12 | SH01 | capital | capital allotment shares |
| 2023-09-20 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-06-12 | AA | accounts | accounts with accounts type full |
| 2023-05-11 | SH01 | capital | capital allotment shares |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
-5.35
DISTRESS
Altman Z″
- Working capital / Total assets -0.198 × 6.56 = -1.30
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.586 × 6.72 = -3.94
- Book equity / Total liabilities -0.108 × 1.05 = -0.11
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory